- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Perspectives In Schizophrenia: Proposed Disease Pathophysiology & Potential Treatment Implications
Virtual Event – Perspectives In Schizophrenia: Proposed Disease Pathophysiology & Potential Treatment Implications
A Virtual Event for PsychU members in Florida.
This presentation examines the proposed pathophysiology of schizophrenia. The discussion will focus on altered neurotransmitter pathways and the evolution of antipsychotics to target multiple receptor types.
Featuring
-
Dante Durand, MD, MBA
Vice Chair of Clinical Services & Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine; Chief Medical Officer at Jackson Behavioral Health Hospital in Miami, FL.
-
Jacquelyn Canning, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison
-
Aneta Fornal, PharmD (OPDC)
Clinical & Scientific Director
Dante Durand, MD, MBA is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Jacquelyn Canning, PharmD, BCPP and Aneta Fornal, PharmD, are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
February 14 3:00 pm to 4:00 pm
Register
This event registration is closed.
Related Events
-
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
February 14 3:00 pm to 4:00 pm
Stay Connected: